État de performance (ECOG 0-1): le patient est entièrement actif ou restreint dans le...
Vue déterministe de l'entité source de la LJAM. L'autorité clinique demeure avec les ID de la source cités et l'état d'approbation de l ́examinateur.
| ID | RF-FITNESS-ECOG-FIT |
|---|---|
| Type | Signal d’alerte |
| État | reviewed 2026-04-27 | pending_clinical_signoff |
| Maladies | Aucune déclaration |
| Sources | SRC-ESMO-DLBCL-2024 SRC-NCCN-BCELL-2025 |
Origine du drapeau rouge
| Définition | État de performance (ECOG 0-1) : le patient est entièrement actif ou restreint dans une activité physique intense mais ambulatoire et capable de réaliser des travaux légers. Éligible pour la chimiothérapie à dose complète et des régimes intensifs (CHOEP, BEACOPP-escalade, HD-MTX, consolidation ASCT, CAR-T). |
|---|---|
| Direction clinique | intensifier |
| Catégorie | aptitude physique |
Logique de déclenchement
{
"any_of": [
{
"comparator": "<=",
"finding": "ecog",
"threshold": 1
}
],
"type": "composite_score"
}
Notes
Pan-disease eligibility gate. ECOG 0-1 is the canonical entry criterion for intensified regimens across DLBCL (CHOEP-21 in age ≤60 with elevated LDH per German High-Grade NHL Study Group), Hodgkin (BEACOPP-escalated), Burkitt (CODOX-M/IVAC, DA-EPOCH-R), CAR-T eligibility. Used in conjunction with organ-function gates. Conflict-resolution: when ECOG-FIT fires alongside RF-ORGAN-* de-escalation, organ-dysfunction wins (de-escalation has higher severity). Replaces free-text "ecog 0-1" all_of clauses across algorithms.
Utilisé par
Algorithmes
ALGO-ACC-1L- ALGO-ACC-1LALGO-CERVICAL-LOCALLY-ADVANCED-1L- ALGO-CERVICAL-LOCALLY-ADVANCED-1LALGO-CLL-1L- ALGO-CLL-1LALGO-DLBCL-1L- ALGO-DLBCL-1LALGO-DLBCL-2L- ALGO-DLBCL-2LALGO-ENDOMETRIAL-2L- ALGO-ENDOMETRIAL-2LALGO-ESOPH-2L- ALGO-ESOPH-2LALGO-ESOPH-RESECTABLE-1L- ALGO-ESOPH-RESECTABLE-1LALGO-FL-2L- ALGO-FL-2LALGO-GASTRIC-2L- ALGO-GASTRIC-2LALGO-GASTRIC-RESECTABLE-PERIOP- ALGO-GASTRIC-RESECTABLE-PERIOPALGO-GBM-NEWLY-DIAGNOSED-1L- ALGO-GBM-NEWLY-DIAGNOSED-1LALGO-GBM-RECURRENT- ALGO-GBM-RECURRENTALGO-GI-NET-ADVANCED-1L- ALGO-GI-NET-ADVANCED-1LALGO-HCC-SYSTEMIC-1L- ALGO-HCC-SYSTEMIC-1LALGO-HCC-SYSTEMIC-2L- ALGO-HCC-SYSTEMIC-2LALGO-HGBL-DH-2L- ALGO-HGBL-DH-2LALGO-HSTCL-1L- ALGO-HSTCL-1LALGO-MCL-2L- ALGO-MCL-2LALGO-MELANOMA-METASTATIC-2L- ALGO-MELANOMA-METASTATIC-2LALGO-MESOTHELIOMA-1L- ALGO-MESOTHELIOMA-1LALGO-MESOTHELIOMA-2L- ALGO-MESOTHELIOMA-2LALGO-MM-1L- ALGO-MM-1LALGO-MM-2L- ALGO-MM-2LALGO-MM-3L- ALGO-MM-3LALGO-NK-T-NASAL-1L- ALGO-NK-T-NASAL-1LALGO-PCNSL-2L- ALGO-PCNSL-2LALGO-PDAC-LAPC- ALGO-PDAC-LAPCALGO-PDAC-METASTATIC-1L- ALGO-PDAC-METASTATIC-1LALGO-PDAC-METASTATIC-2L- ALGO-PDAC-METASTATIC-2LALGO-PDAC-RESECTABLE-PERIOP- ALGO-PDAC-RESECTABLE-PERIOPALGO-PENILE-SCC-1L- ALGO-PENILE-SCC-1LALGO-PMBCL-2L- ALGO-PMBCL-2LALGO-PNET-METASTATIC-1L- ALGO-PNET-METASTATIC-1LALGO-PROSTATE-MHSPC-1L- ALGO-PROSTATE-MHSPC-1LALGO-RCC-METASTATIC-1L- ALGO-RCC-METASTATIC-1LALGO-SCLC-2L- ALGO-SCLC-2LALGO-THYROID-ANAPLASTIC-1L- ALGO-THYROID-ANAPLASTIC-1LALGO-VULVAR-VAGINAL-SCC-1L- ALGO-VULVAR-VAGINAL-SCC-1L